Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale
Author: Zhao, L.
Cavallaro, A.
Wibowo, D.
Zhang, B.
Zhang, J.
Mitter, N.
Yu, C.
Zhao, C.
Middelberg, A.
Citation: Vaccine, 2017; 35(1):77-83
Publisher: Elsevier
Issue Date: 2017
ISSN: 0264-410X
Statement of
Liang Zhao, Antonino S. Cavallaro, David Wibowo, Bing Zhang, Jun Zhang, Neena Mitter, Chengzhong Yu, Chun-Xia Zhao, Anton P.J. Middelberg
Abstract: Anaplasma marginale is a devastating tick-borne pathogen causing anaplasmosis in cattle and results in significant economic loss to the cattle industry worldwide. Currently, there is no widely accepted vaccine against A. marginale. New generation subunit vaccines against A. marginale, which are much safer, more efficient and cost-effective, are in great need. The A. marginale outer membrane protein VirB9-1 is a promising antigen for vaccination. We previously have shown that soluble recombinant VirB9-1 protein can be expressed and purified from Escherichia coli and induce a high level of humoral and cellular immunity in mice. In this study, we re-formulated the nanovaccines using the partially-purified VirB9-1 protein as the antigen and hollow nano-size silica vesicles (SV-100) as the adjuvant. We simplified the purification method to obtain the partially-purified antigen VirB9-1 with a six-fold higher yield. The new formulations using the partially-purified VirB9-1 protein achieved higher antibody and cell-mediated immune responses compared to the purified ones. This finding suggests that the partially-purified VirB9-1 protein performs better than the purified ones in the vaccination against A. marginale, and a certain level of contaminants in the protein antigen can be self-adjuvant and boost immunogenicity together with the nanoparticle adjuvant. This may lead to finding a "Goldilocks" level of contaminants. The new nanovaccine formulation using partially-purified antigens along with nanoparticle adjuvants offers an alternative strategy for making cheaper veterinary vaccines.
Keywords: Anaplasma marginale; partially-purified antigens: aggregates; endotoxin; silica vesicles; immunogenicity
Rights: © 2016 Elsevier Ltd. All rights reserved.
DOI: 10.1016/j.vaccine.2016.11.037
Appears in Collections:Agriculture, Food and Wine publications
Aurora harvest 8

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.